EMEA-001492-PIP02-18

Key facts

Active substance
Trifarotene
Therapeutic area
Dermatology
Decision number
P/0325/2019
PIP number
EMEA-001492-PIP02-18
Pharmaceutical form(s)
Cream
Condition(s) / indication(s)
Treatment of ichthyoses
Route(s) of administration
Topical use
Contact for public enquiries
Premier Research Group SLU

Tel. +61 386147707
E-mail: Niall.Morrissey@maynepharma.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating